Therapeutic endovascular embolization of feeding artery or embolotherapy is growing rapidly by the advancement of novel embolic agents (
5). Patients with complex urologic manifestations are quite a real challenge for working physicians. Indeed, procedures such as pyeloplasty, laser lithotripsy and endopyelotomy are associated with inherent risk of vascular damage (
6). In these cases, trans catheter embolization is effective in the treatment of these vascular injuries. Endourologic interventions have been demonstrated to be valuable in the treatment of acute extravasation in trauma setting, renal AVM, prophylaxis for blood loss before resection of vascular tumors like RCC and angiomyolipomas (
7-
10). The observed problems are all perioperative in nature, ranging from impaired renal function to embolization of non-target organs, manifesting as renal failure and infarction of the contralateral kidney, coil migration, renal vein and inferior vena cava thrombosis, and so on.
This technique necessitates highly trained internationalists, nurses, and technicians, as well as a well-established center-based team approach with a high success rate. In this study, we have achieved high success rate in the endovascular treatment with lower rate of complications. There are many cases of endourologic problems and percutaneous treatment is a good therapeutic option especially in older or comorbidities. We offer advancement of these techniques especially in centers with high expertise and trained interventionists.